”President Trump said Friday he intends to nominate Stephen Hahn, the chief medical officer of MD Anderson Cancer Center in Houston, as the next commissioner of the Food and Drug Administration, a step that resulted in musical chairs involving some of the government’s highest-ranking health jobs.”
“In a surprise move, acting FDA commissioner Norman “Ned” Sharpless, will immediately return to his previous position as the director of the National Cancer Institute. Brett Giroir, assistant secretary for health at the Department of Health and Human Services, will oversee the FDA until Hahn is confirmed, according to HHS Secretary Alex Azar.”
“It had been assumed that Sharpless would run the FDA until Hahn was confirmed. However, his term as acting agency head expired Friday. It couldn’t be extended because the White House has not yet officially nominated Hahn, who is still undergoing…” Read the full article here.
Source: Trump announces plan to nominate Texas cancer doctor to run FDA – By Laurie McGinley, November 1, 2019. Washington Post.
